EGFR and neoplasm: Ero1a (endoplasmic reticulum reductase 1 alpha) is a negative prognostic marker in a variety of tumor types, including in EGFR-mutated forms of non-small cell lung cancer, colon cancer, and hepatocellular carcinoma [43].